Allergic Rhinitis Due to Grass Pollen Clinical Trial
Official title:
Sublingual Immunotherapy Compared to Intralymphatic Immunotherapy With Concomitant Vitamin D, a Randomised Placebo Controlled Study
A national, multicenter, randmised double blind study with parallell arms. 360 patients with grass induced allergic rhinitis will be open randomised 1:2 to 3 years Grazax sublingual immunotherapy or 3 intralymphatic injections with ALK Alutard Timothy. In a second step, the ILIT group will be double blind randomised 1:1 to an intramuscular injection of Vitamin D Vicotrat or placebo, 4 week before the start of the intralymphatic treatment. The primary outcome measure is daily combined symptoms and medication scores during grass pollen season.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03290248 -
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
|
Phase 1/Phase 2 | |
| Completed |
NCT06104293 -
Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass Pollen in ALYATEC Allergen Exposure Chamber
|
N/A | |
| Completed |
NCT04878237 -
Kinetics of Nasal Cytokine Responses to Mechanical Stimulation
|
N/A | |
| Completed |
NCT04802616 -
The Influence of Nonspecific Immunostimulation on Changes in the Concentration of iNKT Cells
|
Phase 3 | |
| Active, not recruiting |
NCT05297760 -
Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract
|
Phase 1/Phase 2 | |
| Completed |
NCT05037955 -
ILIT: Follow-up of Rhinitis Quality of Life
|
||
| Not yet recruiting |
NCT04700852 -
Efficacy of Puressentiel Protective Nasal Spray in Allergic Rhinitis
|
N/A | |
| Active, not recruiting |
NCT05191186 -
Documentation of Efficacy of Intralymphatic Allergen Immunotherapy
|
Phase 3 | |
| Completed |
NCT04210193 -
Is Intralymphatic Allergen Immunotherapy Effective and Safe?
|
Phase 2/Phase 3 | |
| Completed |
NCT01953471 -
Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2)
|
N/A |